rct
    2009
    High Quality

    Alpha lipoic acid in burning mouth syndrome - a randomized double-blind placebo-controlled trial

    Cavalcanti DR, da Silveira FR

    Published in Journal of Oral Pathology & Medicine

    Methodology

    Randomised double-blind placebo-controlled trial of alpha-lipoic acid 600 mg/day for 60 days in burning mouth syndrome.

    Key Findings

    No significant difference between alpha-lipoic acid and placebo; both groups improved similarly.

    Conclusions

    Alpha-lipoic acid did not outperform placebo for burning mouth syndrome.

    Limitations

    Small sample; single centre; short duration.

    Supplements Studied

    Alpha-lipoic acid did not outperform placebo in burning mouth syndrome.

    Outcomes Measured

    Alpha-lipoic acid was no better than placebo for burning mouth pain.

    Related Health Concerns

    Study Details

    Year:2009
    Sample Size:38
    Quality Score:7/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.